Editors' Pick
2 exciting Science papers say Alzheimer's amyloid had MS mice walking
Amyloid has potent anti-inflammatory abilities which may explain what it is trying to do in Alzheimers --and what it succeeded in doing in MS, when Stanford University researchers, led by Lawrence Steinman, systemically delivered it to paralyzed M
Epo short peptide...anyone know about this?
Does anyone know anything more about this?
When will this study be completed?
Any way to get access to this agent now?
"The study is not listed on clinicaltrials.gov which is supposed to list every phase 2 and above clinical trial in the United States. This suggests that the study is in… Read"
Editors' Pick
Papers: 6 Mar 2015 - 13 Mar 2015
Episode 34 with Dr. Jill Hollenbach on killer immunoglobulin like (KIR) receptors
Links to articles and other resources mentioned in Episode 34
Methods
Papers: 27 Feb 2015 - 6 Mar 2015
Newly Dianosed .. need clearer direction on next steps of the process.
This will be somewhat lengthy but I'll try to stay on point.
"Getting a second opinion for something this serious is always a good idea. I suggest finding an MS specialist, even it involves a long drive, and get their input. A… Read"
Help Keep MSDF Alive!
Do you find MSDF invaluable? If so, please help us continue by making a tax-deductible donation NOW.
If you’re reading this message, it’s because you’re one of the 16,000 unique...
Clinical Research, Drug Development, Laboratory Research, Meetings, Methods, People
MS Research Roundup: March 2, 2015
Second PML Case With Fingolimod; Canadian Mesenchymal Stem Cell Trial Set to Go; Charcot Winner: Giancarlo Comi; #GOOB Art; Private Science Funding
Items of interest to multiple sclerosis researchers from around the Web...
Clinical Research, People
Pages
